Advertisement

Topics

Cima Laboratories Incorporated Company Profile

05:20 EDT 20th September 2017 | BioPortfolio

CIMA LABS INC. develops and manufactures prescription and over-the-counter products based upon its proprietary, fast-dissolve drug delivery technologies, OraSolv® and DuraSolv®. Based on our technologies, an active drug ingredient is formulated into a new, orally disintegrating dosage form that dissolves quickly in the mouth without chewing or the need for water.

Location

10000 Valley View Road
Eden Prairie
MN
55344-9361
United States of America

Contact

Phone: 1-952-947-8700
Fax: 1-952-947-8770


News Articles [348 Associated News Articles listed on BioPortfolio]

Contrasting IDEXX Laboratories

IDEXX Laboratories and Heska Corporation are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, di...

Zacks: Brokerages Anticipate Impax Laboratories Inc (IPXL) Will...

Wall Street analysts forecast that Impax Laboratories Inc will post $196.18 million in sales for the current fiscal quarter, Zacks reports. Four analysts have made estimates for Impax Laboratories'...

$0.83 EPS Expected for IDEXX Laboratories, Inc. (IDXX) This Quarter

Brokerages expect that IDEXX Laboratories, Inc. will post $0.83 earnings per share for the current quarter, according to Zacks Investment Research . Four analysts have provided estimates for IDEXX Lab...

Analyzing Impax Laboratories

Pfizer and Impax Laboratories are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional owner...

$0.14 EPS Expected for Impax Laboratories, Inc. (IPXL) This Quarter

Analysts expect Impax Laboratories, Inc. to report earnings per share of $0.14 for the current fiscal quarter, according to Zacks . Four analysts have provided estimates for Impax Laboratories' ea...

State-of-the-art text mining technologies for chemistry

The Biological Text Mining Unit at the Spanish National Cancer Research Centre (CNIO) together with with researchers at the Center for Applied Medical Research (CIMA), of the University of Navarra, i...

Zacks: Analysts Anticipate Impax Laboratories Inc (IPXL) to Announce $0.13 EPS

Equities analysts expect that Impax Laboratories Inc will post earnings per share of $0.13 for the current quarter, according to Zacks Investment Research . Four analysts have made estimates for Impax...

Morning Stock Stories: Impax Laboratories, Inc.

With a market cap of 1.21B, Impax Laboratories, Inc. has a large market cap size. Impax Laboratories, Inc. has been on the stock market since its IPO date on the 12/19/1995.

PubMed Articles [190 Associated PubMed Articles listed on BioPortfolio]

Review of "Safety of Overlapping Surgery at a High-Volume Referral Center" by Hyder JA, Hanson KT, Storlie CB, Glasgow A, Madde NR, Brown MJ, Kor DJ, Cima RR, Habermann EB in Ann Surg 265: 639-644, 2017.

Project management: importance for diagnostic laboratories.

The constraints applied on diagnostic laboratories to improve both quality and productivity together with personal shortages incite laboratory managers to constantly optimize the laboratory workflows,...

Cancer incidence in female laboratory employees: extended follow-up of a Swedish cohort study.

Work in chemical laboratories is associated with exposure to chemicals, of which some are known or suspected carcinogens. A cohort study of laboratory workers in Stockholm followed until 1992 showed a...

This Is not Participatory Design - A Critical Analysis of Eight Living Laboratories.

Design of Health Technology for elderly and care personnel has a high priority because of a severe increase of elderly citizens in need of health care combined with a decrease of resources in the heal...

Consistency of BRCA1 and BRCA2 Variant Classifications Among Clinical Diagnostic Laboratories.

Genetic tests of the cancer predisposition genes BRCA1 and BRCA2 inform significant clinical decisions for both physicians and patients. Most uncovered variants are benign, and determining which few a...

Clinical Trials [232 Associated Clinical Trials listed on BioPortfolio]

A Comparative Clinical Trial to Evaluate the Safety and Clinical Equivalence of Clotrimazole Troche/Lozenges USP, 10mg (Unique Pharmaceutical Laboratories, India) With Clotrimazole Troche 10mg (Roxane Laboratories Inc., USA) in Subjects With Oropharyngeal

The objectives of this study are to compare the efficacy and safety of Clotrimazole troche/ lozenges USP, 10 mg (Unique Pharmaceutical Laboratories, India) vs. Clotrimazole Troche/ Lozenge...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalence Study of Dr.Reddy's Laboratories Limited Finasteride Tablets 1 mg Under Fed Condition

The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Merck & Co. (Propecia®) 1 mg finasteride tablets under fed condi...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalence Study of Dr. Reddy's Laboratories Limited, Finasteride Tablets 1 mg Under Fasting Condition

The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Merck & Co. (Propecia®) 1 mg finasteride tablets under fasting c...

Companies [972 Associated Companies listed on BioPortfolio]

Cima Group

Cima Group is a global telecommunications and digital solutions provider and integrator. Since 1981, Cima Group has provided retail and wholesale voice services, and value-...

Cima Laboratories Incorporated

CIMA LABS INC. develops and manufactures prescription and over-the-counter products based upon its proprietary, fast-dissolve drug delivery technologies, OraSolv® and DuraSolv®. Based on our techn...

CIMA LABS INC

CIMA LABS INC. is a drug delivery technology company. We develop and manufacture prescription and over-the-counter medication based on proprietary, orally disintegrating technologies (also referred to...

Cima NanoTech

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

More Information about "Cima Laboratories Incorporated" on BioPortfolio

We have published hundreds of Cima Laboratories Incorporated news stories on BioPortfolio along with dozens of Cima Laboratories Incorporated Clinical Trials and PubMed Articles about Cima Laboratories Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cima Laboratories Incorporated Companies in our database. You can also find out about relevant Cima Laboratories Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record